ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA committee votes to approve lofexidine for opioid withdrawal
April 03, 2018The US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee has voted to approve lofexidine hydrochloride to treat symptoms of opioid withdrawal. -
FDA Accepts Regulatory Submission and Grants Priority Review for Lofexidine
November 22, 2017Priority Review is granted to submissions for medications that, if approved, would provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions.
Pharma Sources Insight January 2025
